The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Solventum, Minnesota’s newest Fortune 500 company, is finding its footing after starting its first full year of operations on shakier ground. The 3M spinoff commenced 2025 with a deflated stock, which ...

Investing.com - UBS has reiterated its Neutral rating and $79.00 price target on Solventum (NYSE:SOLV) following discussions with the company’s investor relations team about its Acera acquisition and ...

Vacuum-assisted closure (VAC) is a method of decreasing air pressure around a wound to assist the healing. It’s also referred to as negative pressure wound therapy. During a VAC procedure, a ...

Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...

By Bageshri Banerjee May 5 (Reuters) - Medical device maker Solventum said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily driven by strong demand ...

Solventum has a few good businesses, but the market is treating it as a complicated company. Its main parts are MedSurg, Dental, HIS, and a smaller Water / All Other. The thesis says the stock looks ...

Solventum forecasts annual profit at higher end on wound care demand Medical device maker Solventum said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, ...

Solventum has acquired US-based Acera Surgical in a deal worth up to $850m, positioning the company to progress in the synthetic tissue matrices technology space. Solventum, which span out from 3M in ...